BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 37019333)

  • 1. Combining Panel-Based Next-Generation Sequencing and Exome Sequencing for Genetic Liver Diseases.
    Chen CB; Hsu JS; Chen PL; Wu JF; Li HY; Liou BY; Chang MH; Ni YH; Hwu WL; Chien YH; Chou YY; Yang YJ; Lee NC; Chen HL
    J Pediatr; 2023 Jul; 258():113408. PubMed ID: 37019333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic yield and novel candidate genes by next generation sequencing in 166 children with intrahepatic cholestasis.
    Zheng Y; Guo H; Chen L; Cheng W; Yan K; Zhang Z; Li M; Jin Y; Hu G; Wang C; Zhou C; Zhou W; Jia Z; Zheng B; Liu Z
    Hepatol Int; 2024 Apr; 18(2):661-672. PubMed ID: 37314652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a targeted gene panel sequencing for the diagnosis of hereditary chronic liver diseases.
    Ronzoni L; Marini I; Passignani G; Malvestiti F; Marchelli D; Bianco C; Pelusi S; Prati D; Valenti L
    Front Genet; 2023; 14():1137016. PubMed ID: 37388930
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic algorithm for neonatal intrahepatic cholestasis integrating single-gene testing and next-generation sequencing in East Asia.
    Hahn JW; Lee H; Shin M; Seong MW; Moon JS; Ko JS
    J Gastroenterol Hepatol; 2024 May; 39(5):964-974. PubMed ID: 38323732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exome sequencing reveals IFT172 variants in patients with non-syndromic cholestatic liver disease.
    Neřoldová M; Ciara E; Slatinská J; Fraňková S; Lišková P; Kotalová R; Globinovská J; Šafaříková M; Pfeiferová L; Zůnová H; Mrázová L; Stránecký V; Vrbacká A; Fabián O; Sticová E; Skanderová D; Šperl J; Kalousová M; Zima T; Macek M; Pawlowska J; Knisely AS; Kmoch S; Jirsa M
    PLoS One; 2023; 18(7):e0288907. PubMed ID: 37471416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of next generation sequencing (NGS) data re-analysis in the diagnosis of monogenic diseases leading to organ failure.
    Saglia C; Bracciamà V; Trotta L; Mioli F; Faini AC; Brach Del Prever GM; Kalantari S; Luca M; Romeo CM; Scolari C; Peruzzi L; Calvo PL; Mussa A; Fenoglio R; Roccatello D; Alberti C; Carli D; Amoroso A; Deaglio S; Vaisitti T
    BMC Med Genomics; 2023 Nov; 16(1):303. PubMed ID: 38012624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-exome sequencing for genetic diagnosis of idiopathic liver injury in children.
    Lülecioğlu AA; Yazıcı YY; Baran A; Warasnhe K; Beyaz Ş; Aytekin C; Özçay F; Aydemir Y; Barış Z; Belkaya S
    J Cell Mol Med; 2024 Jun; 28(11):e18485. PubMed ID: 38864694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted gene panel provides advantages over whole-exome sequencing for diagnosing obesity and diabetes mellitus.
    Yu H; Yu H; Zhang R; Peng D; Yan D; Gu Y; Bao Y; Jia W; Zhang H; Hu C
    J Mol Cell Biol; 2023 Nov; 15(6):. PubMed ID: 37327085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness of Whole-Genome vs Whole-Exome Sequencing Among Children With Suspected Genetic Disorders.
    Nurchis MC; Radio FC; Salmasi L; Heidar Alizadeh A; Raspolini GM; Altamura G; Tartaglia M; Dallapiccola B; Pizzo E; Gianino MM; Damiani G
    JAMA Netw Open; 2024 Jan; 7(1):e2353514. PubMed ID: 38277144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnosis in patients with monogenic diabetes mellitus, and detection of a novel candidate gene.
    Goksen D; Evin F; Isik E; Ozen S; Atik T; Ozkinay F; Akcan N; Ozkan B; Buyukinan M; Nuri Ozbek M; Darcan S; Onay H
    Diabetes Res Clin Pract; 2023 Nov; 205():110953. PubMed ID: 37838154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Power of NGS-based tests in HSP diagnosis: analysis of massively parallel sequencing in clinical practice.
    Galatolo D; Trovato R; Scarlatti A; Rossi S; Natale G; De Michele G; Barghigiani M; Cioffi E; Filla A; Bilancieri G; Casali C; Santorelli FM; Silvestri G; Tessa A
    Neurogenetics; 2023 Jul; 24(3):147-160. PubMed ID: 37131039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of first-tier whole-exome sequencing with a multi-step traditional approach for diagnosing paediatric outpatients: An Italian prospective study.
    Rosina E; Pezzani L; Apuril E; Pezzoli L; Marchetti D; Bellini M; Lucca C; Meossi C; Massimello M; Mariani M; Scatigno A; Cattaneo E; Colombo L; Maitz S; Cereda A; Milani D; Spaccini L; Bedeschi MF; Selicorni A; Iascone M
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2316. PubMed ID: 38041506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of genetic disorders in childhood with next-generation sequencing].
    Menyhárt O; Győrffy B; Szabó A
    Orv Hetil; 2022 Dec; 163(51):2027-2040. PubMed ID: 36528826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing diagnosis and management of liver disease in adults through exome sequencing.
    Zheng M; Hakim A; Konkwo C; Deaton AM; Ward LD; ; Silveira MG; Assis DN; Liapakis A; Jaffe A; Jiang ZG; Curry MP; Lai M; Cho MH; Dykas D; Bale A; Mistry PK; Vilarinho S
    EBioMedicine; 2023 Sep; 95():104747. PubMed ID: 37566928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exome sequencing as first-tier genetic testing in infantile-onset pharmacoresistant epilepsy: diagnostic yield and treatment impact.
    Boonsimma P; Ittiwut C; Kamolvisit W; Ittiwut R; Chetruengchai W; Phokaew C; Srichonthong C; Poonmaksatit S; Desudchit T; Suphapeetiporn K; Shotelersuk V
    Eur J Hum Genet; 2023 Feb; 31(2):179-187. PubMed ID: 36198807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High diagnostic yield of targeted next-generation sequencing panel as a first-tier molecular test for the patients with myopathy or muscular dystrophy.
    Çavdarlı B; Köken ÖY; Satılmış SBA; Bilen Ş; Ardıçlı D; Ceylan AC; Gündüz CNS; Topaloğlu H
    Ann Hum Genet; 2023 May; 87(3):104-114. PubMed ID: 36575883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are the new genetic tools for diagnosis of Wilson disease helpful in clinical practice?
    Espinós C; Ferenci P
    JHEP Rep; 2020 Aug; 2(4):100114. PubMed ID: 32613181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Yield of Next Generation Sequencing in Genetically Undiagnosed Patients with Primary Immunodeficiencies: a Systematic Review.
    Yska HAF; Elsink K; Kuijpers TW; Frederix GWJ; van Gijn ME; van Montfrans JM
    J Clin Immunol; 2019 Aug; 39(6):577-591. PubMed ID: 31250335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the European Society of Cardiology guidelines and whole exome sequencing on genetic testing in hereditary cardiac diseases.
    Mio C; Zucco J; Fabbro D; Bregant E; Baldan F; Allegri L; D'Elia AV; Collini V; Imazio M; Damante G; Faletra F
    Clin Genet; 2024 Jun; ():. PubMed ID: 38837338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next generation sequencing (NGS)-based approach to diagnosing Algerian patients with suspected inborn errors of immunity (IEIs).
    Peng XP; Al-Ddafari MS; Caballero-Oteyza A; El Mezouar C; Mrovecova P; Dib SE; Massen Z; Smahi MC; Faiza A; Hassaïne RT; Lefranc G; Aribi M; Grimbacher B
    Clin Immunol; 2023 Nov; 256():109758. PubMed ID: 37678716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.